ConductScience.org, home

Paper15057741

Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.

Shiffman ML and 14 others. Gastroenterology, 2004. Cited by 363 papers, by iCite.

Cite this record

ConductScience Library. Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment. Papers, record 15057741. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15057741

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.
PubMed
Journal
Gastroenterology
PubMed
Year
2004
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
363
iCite
Relative citation ratio, by iCite
9.65
iCite
Revised in PubMed
2019-07-07
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shiffman MLMitchell L
2Di Bisceglie AMAdrian M
3Lindsay KLKaren L
4Morishima CChihiro
5Wright ECElizabeth C
6Everson GTGregory T
7Lok ASAnna S
8Morgan TRTimothy R
9Bonkovsky HLHerbert L
10Lee WMWilliam M
11Dienstag JLJules L
12Ghany MGMarc G
13Goodman ZDZachary D
14Everhart JEJames E
15Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial GroupGroup

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
Hepatitis C, ChronicMajor topic
Interferon-alphaMajor topic
Polyethylene GlycolsMajor topic
RibavirinMajor topic
Adult
Aged
Aged, 80 and over
Drug Therapy, Combination
Female
Humans
Interferon alpha-2
Liver Cirrhosis
Male
Middle Aged
Prospective Studies
Recombinant Proteins
Treatment Failure

Source PubMed

Download CSV of topics

Grants19

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
M01RR-00042NCRR NIH HHSUnited StatesM01RR000042PubMed and NIHNIH RePORTER
M01RR-00043NCRR NIH HHSUnited StatesM01RR000043PubMed and NIHNIH RePORTER
M01RR-00051NCRR NIH HHSUnited StatesM01RR000051PubMed and NIHNIH RePORTER
M01RR-00065NCRR NIH HHSUnited StatesM01RR000065PubMed and NIHNIH RePORTER
M01RR-00633NCRR NIH HHSUnited StatesM01RR000633PubMed and NIHNIH RePORTER
M01RR-00827NCRR NIH HHSUnited StatesM01RR000827PubMed and NIHNIH RePORTER
M01RR-01066NCRR NIH HHSUnited StatesM01RR001066PubMed and NIHNIH RePORTER
M01RR-06192NCRR NIH HHSUnited StatesM01RR006192PubMed and NIHNIH RePORTER
N01-DK-9-2318NIDDK NIH HHSUnited StatesN01DK092318PubMed and NIHNIH RePORTER
N01-DK-9-2319NIDDK NIH HHSUnited StatesN01DK092319PubMed and NIHNIH RePORTER
N01-DK-9-2320NIDDK NIH HHSUnited StatesN01DK092320PubMed and NIHNIH RePORTER
N01-DK-9-2321NIDDK NIH HHSUnited StatesN01DK092321PubMed and NIHNIH RePORTER
N01-DK-9-2322NIDDK NIH HHSUnited StatesN01DK092322PubMed and NIHNIH RePORTER
N01-DK-9-2323NIDDK NIH HHSUnited StatesN01DK092323PubMed and NIHNIH RePORTER
N01-DK-9-2324NIDDK NIH HHSUnited StatesN01DK092324PubMed and NIHNIH RePORTER
N01-DK-9-2325NIDDK NIH HHSUnited StatesN01DK092325PubMed and NIHNIH RePORTER
N01-DK-9-2326NIDDK NIH HHSUnited StatesN01DK092326PubMed and NIHNIH RePORTER
N01-DK-9-2327NIDDK NIH HHSUnited StatesN01DK092327PubMed and NIHNIH RePORTER
N01-DK-9-2328NIDDK NIH HHSUnited StatesN01DK092328PubMed and NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00491179Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose RibavirinBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by108

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 363 citations.

PMIDTitleJournalYearIn PapersSource
41157571Oncogenic Viruses in Organ Transplantation: Implications of Virus-Host Interactions for Cancer Development.Viruses2025https://conductscience.org/library/papers/41157571PubMed
36125059Cost-effectiveness of direct-acting antivirals for chronic hepatitis C virus in the United States from a payer perspective.J Manag Care Spec Pharm2022https://conductscience.org/library/papers/36125059PubMed
35626332Perceived Stress in Hepatitis C Virus Infected Patients under the DAA-Based Therapy.Diagnostics (Basel)2022https://conductscience.org/library/papers/35626332PubMed
32764876Danoprevir for the Treatment of Hepatitis C Virus Infection: Design, Development, and Place in Therapy.Drug Des Devel Ther2020https://conductscience.org/library/papers/32764876PubMed
28469364
Efficacy and safety profile of boceprevir- or telaprevir-based triple therapy or dual peginterferon alfa-2a or alfa-2b plus ribavirin therapy in chronic hepatitis C: the real-world PegBase observational study.
Ann Gastroenterol2017https://conductscience.org/library/papers/28469364PubMed
28232944Favorable Outcomes of Chinese HCV-Related Cirrhotic Patients with Sustained Virological Response after Pegylated Interferon Plus Ribavirin Treatment.Biomed Res Int2017https://conductscience.org/library/papers/28232944PubMed
27882182Disease progression in Chinese patients with hepatitis C virus RNA-positive infection via blood transfusion.Exp Ther Med2016https://conductscience.org/library/papers/27882182PubMed
27832143Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials.PLoS One2016https://conductscience.org/library/papers/27832143PubMed
27377910Efficacy and safety of daclatasvir and asunaprevir for hepatitis C virus genotype 1b infection.Clin Mol Hepatol2016https://conductscience.org/library/papers/27377910PubMed
27246107Evidence-based clinical practice guidelines for liver cirrhosis 2015.J Gastroenterol2016https://conductscience.org/library/papers/27246107PubMed
27044763KASL clinical practice guidelines: management of hepatitis C.Clin Mol Hepatol2016https://conductscience.org/library/papers/27044763PubMed
26629360Re-treatment of patients with chronic hepatitis C virus genotype 4 infection with pegylated interferon and ribavirin: a meta-analysis.BMJ Open Gastroenterol2015https://conductscience.org/library/papers/26629360PubMed
26342813Treatment of HCV in Patients who Failed First-Generation PI Therapy: a Review of Current Literature.Curr Gastroenterol Rep2015https://conductscience.org/library/papers/26342813PubMed
26201405APASL consensus statements and management algorithms for hepatitis C virus infection.Hepatol Int2012https://conductscience.org/library/papers/26201405PubMed
26185714Retreatment of Chronic Hepatitis C Infection with Telaprevir: Preliminary Results in Turkey.Balkan Med J2015https://conductscience.org/library/papers/26185714PubMed
25914454Management of hepatitis C infection before and after liver transplantation.World J Gastroenterol2015https://conductscience.org/library/papers/25914454PubMed
25755575Sustained virological response rates to antiviral therapy in genotype 1 and 3 chronic hepatitis C patients: a study from north India.J Clin Exp Hepatol2014https://conductscience.org/library/papers/25755575PubMed
25032178KASL clinical practice guidelines: management of hepatitis C.Clin Mol Hepatol2014https://conductscience.org/library/papers/25032178PubMed
24886378Processes to manage analyses and publications in a phase III multicenter randomized clinical trial.Trials2014https://conductscience.org/library/papers/24886378PubMed
24834289Evaluated outcomes in patients with Chronic Hepatitis C.Gastroenterol Hepatol Bed Bench2013https://conductscience.org/library/papers/24834289PubMed

See all 108 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IFNA23440PubTator's text mininghttps://conductscience.org/library/genes/3440NCBI Gene
SLC17A526503PubTator's text mininghttps://conductscience.org/library/genes/26503NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/15057741

GET https://conductscience.org/api/papers/v1/15057741/cited_by?page=2